Evidence map›Paper›PMID 39866344›Full record

ArticleOphthalmology science

Deep-Reticular Pseudodrusen-Net: A 3-Dimensional Deep Network for Detection of Reticular Pseudodrusen on OCT Scans.

Amr Elsawy, Tiarnan D L Keenan, Alisa T Thavikulwat, Amy Lu, Sunil Bellur, Souvick Mukherjee, Elvira Agron, Qingyu Chen, Emily Y Chew, Zhiyong Lu

Abstract read
In one paragraph

Article in Ophthalmology science. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Amr ElsawyNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland.
Tiarnan D L KeenanDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Alisa T ThavikulwatDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Amy LuDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Sunil BellurDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Souvick MukherjeeDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Elvira AgronDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Qingyu ChenNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland.
Emily Y ChewDivision of Epidemiology and Clinical Applications, National Eye Institute, National Institutes of Health, Bethesda, Maryland.
Zhiyong LuNational Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, Maryland.

Funding

Natural language processing and medical imaging analysis for multi-modality computer assisted diagnosis of ophthalmic diseasesK99LM014024 · NLM · YALE UNIVERSITY · PI CHEN, QINGYU · 2023 to 2023
$92k
NLM NIH HHS K99 LM014024
6 · The paper itself

Abstract

Objective: To propose Deep-RPD-Net, a 3-dimensional deep learning network with semisupervised learning (SSL) for the detection of reticular pseudodrusen (RPD) on spectral-domain OCT scans, explain its decision-making, and compare it with baseline methods. Design: Deep learning model development. Participants: Three hundred fifteen participants from the Age-Related Eye Disease Study 2 Ancillary OCT Study (AREDS2) and 161 participants from the Dark Adaptation in Age-related Macular Degeneration Study (DAAMD). Methods: Two datasets comprising of 1304 (826 labeled) and 1479 (1366 labeled) OCT scans were used to develop and evaluate Deep-RPD-Net and baseline models. The AREDS2 RPD labels were transferred from fundus autofluorescence images, which were captured at the same visit for OCT scans, and DAAMD RPD labels were obtained from the Wisconsin reading center. The datasets were divided into 70%, 10%, and 20% at the participant level for training, validation, and test sets, respectively, for the baseline model. Then, SSL was used with the unlabeled OCT scans to improve the trained model. The performance of Deep-RPD-Net was compared to that of 3 retina specialists on a subset of 50 OCT scans for each dataset. En face and B-scan heatmaps of all networks were visualized and graded on 25 OCT scans with positive labels, using a scale of 1 to 4, to explore the models' decision-making. Main Outcome Measures: Accuracy and area under the receiver-operating characteristic curve (AUROC). Results: Deep-RPD-Net achieved the highest performance metrics, with accuracy and AUROC of 0.81 (95% confidence interval [CI]: 0.76-0.87) and 0.91 (95% CI: 0.86-0.95) on the AREDS2 dataset and 0.80 (95% CI: 0.75-0.84) and 0.86 (95% CI: 0.79-0.91) on the DAAMD dataset. On the subjective test, it achieved accuracy of 0.84 compared with 0.76 for the most accurate retina specialist on the AREDS2 dataset and 0.82 compared with 0.84 on the DAAMD dataset. It also achieved the highest visualization grades, of 3.26 and 3.32 for en face and B-scan heatmaps, respectively. Conclusions: Deep-RPD-Net was able to detect RPD accurately from OCT scans. The visualizations of Deep-RPD-Net were the most explainable to the retina specialist with the highest accuracy. The code and pretrained models are publicly available at https://github.com/ncbi-nlp/Deep-RPD-Net. Financial Disclosures: Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.

Indexed as

Age-related macular degenerationDeep learningDetectionOCTReticular pseudodrusen

Identifiers

PMID39866344
PMCPMC11758204

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.